#VisualAbstract: Tislelizumab plus chemotherapy improves outcomes for advanced squamous NSCLC over chemotherapy alone

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, COVID-19 Room

#VisualAbstract: Tislelizumab plus chemotherapy improves outcomes for advanced squamous NSCLC over chemotherapy alone

2 Minute Medicine

Apr 13, 2021

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

Visual Abstracts Regulatory alerts

Quality Evidence Briefings, Cancer, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

2 Minute Medicine

Apr 09, 2021

#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Skin cancer, Oncology Room

#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma

2 Minute Medicine

Apr 07, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, COVID-19 Room

#VisualAbstract: Azithromycin does not improve clinical outcomes in high-risk patients with suspected COVID-19 in the community setting

2 Minute Medicine

Apr 07, 2021

#VisualAbstract: Direct oral anticoagulants may be the superior treatment for patients with atrial fibrillation on dialysis

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cardiology, Cardiovascular conditions

#VisualAbstract: Direct oral anticoagulants may be the superior treatment for patients with atrial fibrillation on dialysis

2 Minute Medicine

Apr 06, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract: Chlormethine gel shows importance in real-world therapeutics in combination with other therapies for mycosis fungoides cutaneous T-cell lymphoma

2 Minute Medicine

Apr 02, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Head and neck cancer, Oncology Room

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

2 Minute Medicine

Apr 01, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract: TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

2 Minute Medicine

Apr 01, 2021

#VisualAbstract: Reinfection rates among patients previously testing positive for COVID-19

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Infections, COVID-19 Room

#VisualAbstract: Reinfection rates among patients previously testing positive for COVID-19

2 Minute Medicine

Apr 01, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Diabetes, Endocrinological conditions other than diabetes

#VisualAbstract: Semaglutide 2.4 mg once a week decreases bodyweight in overweight or obese patients with type 2 diabetes

2 Minute Medicine

Mar 31, 2021

#VisualAbstract: Pirtobrutinib is safe and efficacious in the treatment of relapsed or refractory B-cell malignancies (BRUIN Trial)

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Oncology Room

#VisualAbstract: Pirtobrutinib is safe and efficacious in the treatment of relapsed or refractory B-cell malignancies (BRUIN Trial)

2 Minute Medicine

Mar 30, 2021

#VisualAbstract Dexamethasone improved isatuximab efficacy in patients with relapsed/refractory multiple myeloma

Quality Evidence Briefings Visual Abstracts

Cancer, Oncology, Oncology Room

#VisualAbstract Dexamethasone improved isatuximab efficacy in patients with relapsed/refractory multiple myeloma

2 Minute Medicine

Mar 26, 2021

#VisualAbstract: Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in Hodgkin lymphoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Haematology, Oncology, Oncology Room

#VisualAbstract: Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in Hodgkin lymphoma

2 Minute Medicine

Mar 25, 2021

#VisualAbstract: BRAF and MEK inhibitor combination therapy shows efficacy for advanced melanoma in Japanese patients

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Oncology Room

#VisualAbstract: BRAF and MEK inhibitor combination therapy shows efficacy for advanced melanoma in Japanese patients

2 Minute Medicine

Mar 25, 2021

#VisualAbstract CARDAMON case series: Thrombotic microangiopathy in newly diagnosed multiple myeloma patients receiving carfilzomib, cyclophosphamide, and dexamethasone can be preventatively managed

Quality Evidence Briefings Visual Abstracts

Blood and immune system conditions, Cancer, Oncology, Oncology Room

#VisualAbstract CARDAMON case series: Thrombotic microangiopathy in newly diagnosed multiple myeloma patients receiving carfilzomib, cyclophosphamide, and dexamethasone can be preventatively managed

2 Minute Medicine

Mar 25, 2021

Quality Evidence Briefings Visual Abstracts

Oncology, Breast cancer, Oncology Room

#VisualAbstract: Early discontinuation of endocrine therapy may increase risk of breast cancer recurrence in premenopausal women

2 Minute Medicine

Mar 24, 2021

#VisualAbstract: ChAdOx1-nCoV-19 vaccine maintains efficacy despite a longer prime-boost interval

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, COVID-19 Room

#VisualAbstract: ChAdOx1-nCoV-19 vaccine maintains efficacy despite a longer prime-boost interval

2 Minute Medicine

Mar 24, 2021

#VisualAbstract: Short-course antimicrobial therapy effective for pediatric community-acquired pneumonia

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Infections, Paediatrics

#VisualAbstract: Short-course antimicrobial therapy effective for pediatric community-acquired pneumonia

2 Minute Medicine

Mar 23, 2021

#VisualAbstract MRCN-003/CCTGMYX.1: Weekly carfilzomib, cyclophosphamide, and dexamethasone may be a safe and effective option for patients with relapsed/refractory multiple myeloma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Oncology Room

#VisualAbstract MRCN-003/CCTGMYX.1: Weekly carfilzomib, cyclophosphamide, and dexamethasone may be a safe and effective option for patients with relapsed/refractory multiple myeloma

2 Minute Medicine

Mar 19, 2021

#VisualAbstract: Nivolumab plus ipilimumab is safe and effective for the treatment of advanced melanoma (CheckMate 218)

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Oncology Room

#VisualAbstract: Nivolumab plus ipilimumab is safe and effective for the treatment of advanced melanoma (CheckMate 218)

2 Minute Medicine

Mar 18, 2021